Sector consensus Charles River Laboratories International, Inc. Berne S.E.

Stocks

End-of-day quote Berne S.E. 2026-08-14			5-day change	1st Jan Change
225.03 ^CHF	-2.88%		+5.49%	-

08-13	Charles River Laboratories International Insider Sold Shares Worth $1,038,657, According to a Recent SEC Filing	MT
08-10	TD Cowen Adjusts PT on Charles River Laboratories International to $300 From $235, Maintains Buy Rating	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Analysts' target price evolution (4 months)	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Average Target P.	Objective/dr gap	Nbr of analysts
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-	-	-	-	-	-	-
LONZA GROUP AG					681.13	+21.07%	23
REVOLUTION MEDICINES, INC.					221.9	+8.93%	21
BEONE MEDICINES AG					433.02	+24.62%	27
IQVIA HOLDINGS INC.					275.17	+16.27%	18
CELLTRION, INC.					264,708.89	+31.7%	24
ASCENDIS PHARMA A/S					267.92	+24.83%	18
MEDPACE HOLDINGS, INC.					581.83	+0.58%	12
EUROFINS SCIENTIFIC SE					72.53	+2.96%	14
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.					281	+0.34%	14
ICON PUBLIC LIMITED COMPANY					185.56	+13.74%	16
PHARMARON BEIJING CO., LTD.					38.15	-22.33%	11
BIO-TECHNE CORPORATION					70.73	-2.31%	11
ABIVAX					138.97	+35.32%	6
PRAXIS PRECISION MEDICINES, INC.					623.68	+70.03%	19
APOGEE THERAPEUTICS, INC.					134.85	+0.22%	11
PROTAGONIST THERAPEUTICS, INC.					165.31	+6.58%	13
KYMERA THERAPEUTICS, INC.					130.91	+11.52%	22
IONIS PHARMACEUTICALS, INC.					89.33	+56.07%	21
TEMPUS AI, INC.					62.64	+20.24%	14
Average					14,166.5	+16.86%	17
Weighted average by Cap.					23,714.16	+17.29%	19